Imunon, Inc. — Director's Dealing 2015

Aug 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2015-08-10

Reporting Person: Tardugno Michael H (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-10	Celsion Corporation Common Stock	P	5000	$2.285	Acquired	79521	Direct

Footnotes

F1: The Officer purchased the shares on the open market

F2: Represents the weighted average purchase price per share of common stock purchased. The prices of stock purchased ranged from $2.27 to $2.30.